Cara Therapeutics, Inc. (CARA) Financials
CARA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 125.8 million | 68.8 million |
2023-09-30 | 115.3 million | 29.7 million |
2023-06-30 | 134.4 million | 25.5 million |
2023-03-31 | 153.3 million | 16.7 million |
CARA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -19.4 million | 3.6 million |
2023-09-30 | -20.0 million | 3.3 million |
2023-06-30 | -20.4 million | 3.4 million |
2023-03-31 | -34.6 million | 3.4 million |
CARA Net Income
No data available :(
CARA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 101.2 million | - | 6.1 million |
2023-09-30 | 78.5 million | - | 7.3 million |
2023-06-30 | 94.7 million | - | 982000 |
2023-03-31 | 114.3 million | - | 1.5 million |
CARA Shares Outstanding
CARA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 2.1 million | 28.4 million | 6.5 million | - |
2023-09-30 | 323000 | 25.5 million | 6.8 million | - |
2023-06-30 | 323000 | 30.3 million | 7.5 million | - |
2023-03-31 | 323000 | 24.3 million | 6.9 million | - |
CARA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 3.0 million | 690000 |
2023-09-30 | 4.9 million | 1.6 million |
2023-06-30 | 6.9 million | 1.4 million |
2023-03-31 | 6.2 million | 2.6 million |
CARA
Price: $0.78
52 week price:
Earnings Per Share: -2.19 USD
P/E Ratio: -0.27
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 393100
Ebitda: -12.8 millionMarket Capitalization: 46.5 million